nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—ABCB1—Mitomycin—urinary bladder cancer	0.264	0.357	CbGbCtD
Nizatidine—BCHE—Cisplatin—urinary bladder cancer	0.218	0.294	CbGbCtD
Nizatidine—ABCB1—Gemcitabine—urinary bladder cancer	0.076	0.103	CbGbCtD
Nizatidine—ABCB1—Cisplatin—urinary bladder cancer	0.0552	0.0746	CbGbCtD
Nizatidine—ABCB1—Etoposide—urinary bladder cancer	0.0543	0.0733	CbGbCtD
Nizatidine—ABCB1—Doxorubicin—urinary bladder cancer	0.037	0.05	CbGbCtD
Nizatidine—ABCB1—Methotrexate—urinary bladder cancer	0.0358	0.0484	CbGbCtD
Nizatidine—Myalgia—Fluorouracil—urinary bladder cancer	0.00068	0.00261	CcSEcCtD
Nizatidine—Chest pain—Fluorouracil—urinary bladder cancer	0.00068	0.00261	CcSEcCtD
Nizatidine—Constipation—Thiotepa—urinary bladder cancer	0.000674	0.00259	CcSEcCtD
Nizatidine—Pain—Thiotepa—urinary bladder cancer	0.000674	0.00259	CcSEcCtD
Nizatidine—Back pain—Etoposide—urinary bladder cancer	0.000671	0.00258	CcSEcCtD
Nizatidine—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000663	0.00255	CcSEcCtD
Nizatidine—Infection—Gemcitabine—urinary bladder cancer	0.000658	0.00253	CcSEcCtD
Nizatidine—Irritability—Methotrexate—urinary bladder cancer	0.000658	0.00253	CcSEcCtD
Nizatidine—Confusional state—Fluorouracil—urinary bladder cancer	0.000657	0.00253	CcSEcCtD
Nizatidine—Convulsion—Cisplatin—urinary bladder cancer	0.000656	0.00252	CcSEcCtD
Nizatidine—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000652	0.00251	CcSEcCtD
Nizatidine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000649	0.0025	CcSEcCtD
Nizatidine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000649	0.00249	CcSEcCtD
Nizatidine—Infection—Fluorouracil—urinary bladder cancer	0.000647	0.00249	CcSEcCtD
Nizatidine—Myalgia—Cisplatin—urinary bladder cancer	0.000644	0.00248	CcSEcCtD
Nizatidine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000644	0.00248	CcSEcCtD
Nizatidine—Anxiety—Cisplatin—urinary bladder cancer	0.000642	0.00247	CcSEcCtD
Nizatidine—Anaemia—Etoposide—urinary bladder cancer	0.000641	0.00246	CcSEcCtD
Nizatidine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000641	0.00246	CcSEcCtD
Nizatidine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000638	0.00245	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000633	0.00243	CcSEcCtD
Nizatidine—Anorexia—Gemcitabine—urinary bladder cancer	0.000632	0.00243	CcSEcCtD
Nizatidine—Urticaria—Thiotepa—urinary bladder cancer	0.000626	0.00241	CcSEcCtD
Nizatidine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000623	0.00239	CcSEcCtD
Nizatidine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000623	0.00239	CcSEcCtD
Nizatidine—Anorexia—Fluorouracil—urinary bladder cancer	0.000621	0.00239	CcSEcCtD
Nizatidine—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000618	0.00237	CcSEcCtD
Nizatidine—Infection—Cisplatin—urinary bladder cancer	0.000614	0.00236	CcSEcCtD
Nizatidine—Cough—Etoposide—urinary bladder cancer	0.000605	0.00233	CcSEcCtD
Nizatidine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000605	0.00233	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000604	0.00232	CcSEcCtD
Nizatidine—Convulsion—Etoposide—urinary bladder cancer	0.000601	0.00231	CcSEcCtD
Nizatidine—Insomnia—Gemcitabine—urinary bladder cancer	0.000599	0.0023	CcSEcCtD
Nizatidine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000597	0.0023	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000594	0.00228	CcSEcCtD
Nizatidine—Chest pain—Etoposide—urinary bladder cancer	0.00059	0.00227	CcSEcCtD
Nizatidine—Eosinophilia—Methotrexate—urinary bladder cancer	0.00059	0.00227	CcSEcCtD
Nizatidine—Insomnia—Fluorouracil—urinary bladder cancer	0.000589	0.00227	CcSEcCtD
Nizatidine—Somnolence—Gemcitabine—urinary bladder cancer	0.000589	0.00227	CcSEcCtD
Nizatidine—Anorexia—Cisplatin—urinary bladder cancer	0.000589	0.00226	CcSEcCtD
Nizatidine—Somnolence—Fluorouracil—urinary bladder cancer	0.000579	0.00223	CcSEcCtD
Nizatidine—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000577	0.00222	CcSEcCtD
Nizatidine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000576	0.00221	CcSEcCtD
Nizatidine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000573	0.00221	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000572	0.0022	CcSEcCtD
Nizatidine—Confusional state—Etoposide—urinary bladder cancer	0.000571	0.00219	CcSEcCtD
Nizatidine—Pain—Gemcitabine—urinary bladder cancer	0.000567	0.00218	CcSEcCtD
Nizatidine—Constipation—Gemcitabine—urinary bladder cancer	0.000567	0.00218	CcSEcCtD
Nizatidine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000566	0.00218	CcSEcCtD
Nizatidine—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000566	0.00218	CcSEcCtD
Nizatidine—Asthenia—Thiotepa—urinary bladder cancer	0.000565	0.00217	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000563	0.00216	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000562	0.00216	CcSEcCtD
Nizatidine—Infection—Etoposide—urinary bladder cancer	0.000562	0.00216	CcSEcCtD
Nizatidine—Pruritus—Thiotepa—urinary bladder cancer	0.000557	0.00214	CcSEcCtD
Nizatidine—Pain—Fluorouracil—urinary bladder cancer	0.000557	0.00214	CcSEcCtD
Nizatidine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000554	0.00213	CcSEcCtD
Nizatidine—Eosinophilia—Epirubicin—urinary bladder cancer	0.000552	0.00212	CcSEcCtD
Nizatidine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000549	0.00211	CcSEcCtD
Nizatidine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000547	0.0021	CcSEcCtD
Nizatidine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000546	0.0021	CcSEcCtD
Nizatidine—Anorexia—Etoposide—urinary bladder cancer	0.000539	0.00207	CcSEcCtD
Nizatidine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000539	0.00207	CcSEcCtD
Nizatidine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000537	0.00206	CcSEcCtD
Nizatidine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000537	0.00206	CcSEcCtD
Nizatidine—Pneumonia—Methotrexate—urinary bladder cancer	0.000534	0.00206	CcSEcCtD
Nizatidine—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000534	0.00205	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000533	0.00205	CcSEcCtD
Nizatidine—Pain—Cisplatin—urinary bladder cancer	0.000528	0.00203	CcSEcCtD
Nizatidine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000524	0.00201	CcSEcCtD
Nizatidine—Dizziness—Thiotepa—urinary bladder cancer	0.000521	0.002	CcSEcCtD
Nizatidine—Urticaria—Fluorouracil—urinary bladder cancer	0.000518	0.00199	CcSEcCtD
Nizatidine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000515	0.00198	CcSEcCtD
Nizatidine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000511	0.00196	CcSEcCtD
Nizatidine—Sweating—Methotrexate—urinary bladder cancer	0.000509	0.00196	CcSEcCtD
Nizatidine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000509	0.00196	CcSEcCtD
Nizatidine—Somnolence—Etoposide—urinary bladder cancer	0.000503	0.00193	CcSEcCtD
Nizatidine—Vomiting—Thiotepa—urinary bladder cancer	0.000501	0.00193	CcSEcCtD
Nizatidine—Pneumonia—Epirubicin—urinary bladder cancer	0.0005	0.00192	CcSEcCtD
Nizatidine—Rash—Thiotepa—urinary bladder cancer	0.000497	0.00191	CcSEcCtD
Nizatidine—Dermatitis—Thiotepa—urinary bladder cancer	0.000496	0.00191	CcSEcCtD
Nizatidine—Headache—Thiotepa—urinary bladder cancer	0.000493	0.0019	CcSEcCtD
Nizatidine—Decreased appetite—Etoposide—urinary bladder cancer	0.000492	0.00189	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000488	0.00188	CcSEcCtD
Nizatidine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000488	0.00188	CcSEcCtD
Nizatidine—Jaundice—Epirubicin—urinary bladder cancer	0.000485	0.00186	CcSEcCtD
Nizatidine—Constipation—Etoposide—urinary bladder cancer	0.000484	0.00186	CcSEcCtD
Nizatidine—Pain—Etoposide—urinary bladder cancer	0.000484	0.00186	CcSEcCtD
Nizatidine—Hepatitis—Methotrexate—urinary bladder cancer	0.000477	0.00183	CcSEcCtD
Nizatidine—Sweating—Epirubicin—urinary bladder cancer	0.000477	0.00183	CcSEcCtD
Nizatidine—Asthenia—Gemcitabine—urinary bladder cancer	0.000475	0.00183	CcSEcCtD
Nizatidine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000473	0.00182	CcSEcCtD
Nizatidine—Pruritus—Gemcitabine—urinary bladder cancer	0.000469	0.0018	CcSEcCtD
Nizatidine—Nausea—Thiotepa—urinary bladder cancer	0.000468	0.0018	CcSEcCtD
Nizatidine—Sinusitis—Epirubicin—urinary bladder cancer	0.000467	0.00179	CcSEcCtD
Nizatidine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000466	0.00179	CcSEcCtD
Nizatidine—Pneumonia—Doxorubicin—urinary bladder cancer	0.000463	0.00178	CcSEcCtD
Nizatidine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000463	0.00178	CcSEcCtD
Nizatidine—Pruritus—Fluorouracil—urinary bladder cancer	0.000461	0.00177	CcSEcCtD
Nizatidine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000453	0.00174	CcSEcCtD
Nizatidine—Urticaria—Etoposide—urinary bladder cancer	0.00045	0.00173	CcSEcCtD
Nizatidine—Jaundice—Doxorubicin—urinary bladder cancer	0.000449	0.00172	CcSEcCtD
Nizatidine—Rhinitis—Epirubicin—urinary bladder cancer	0.000448	0.00172	CcSEcCtD
Nizatidine—Body temperature increased—Etoposide—urinary bladder cancer	0.000447	0.00172	CcSEcCtD
Nizatidine—Abdominal pain—Etoposide—urinary bladder cancer	0.000447	0.00172	CcSEcCtD
Nizatidine—Hepatitis—Epirubicin—urinary bladder cancer	0.000446	0.00172	CcSEcCtD
Nizatidine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000446	0.00171	CcSEcCtD
Nizatidine—Asthenia—Cisplatin—urinary bladder cancer	0.000443	0.0017	CcSEcCtD
Nizatidine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000443	0.0017	CcSEcCtD
Nizatidine—Sweating—Doxorubicin—urinary bladder cancer	0.000441	0.0017	CcSEcCtD
Nizatidine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000432	0.00166	CcSEcCtD
Nizatidine—Dizziness—Fluorouracil—urinary bladder cancer	0.000431	0.00166	CcSEcCtD
Nizatidine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000423	0.00162	CcSEcCtD
Nizatidine—Vomiting—Gemcitabine—urinary bladder cancer	0.000421	0.00162	CcSEcCtD
Nizatidine—Rash—Gemcitabine—urinary bladder cancer	0.000418	0.00161	CcSEcCtD
Nizatidine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000417	0.00161	CcSEcCtD
Nizatidine—Headache—Gemcitabine—urinary bladder cancer	0.000415	0.0016	CcSEcCtD
Nizatidine—Vomiting—Fluorouracil—urinary bladder cancer	0.000414	0.00159	CcSEcCtD
Nizatidine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000414	0.00159	CcSEcCtD
Nizatidine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000413	0.00159	CcSEcCtD
Nizatidine—Rash—Fluorouracil—urinary bladder cancer	0.000411	0.00158	CcSEcCtD
Nizatidine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00041	0.00158	CcSEcCtD
Nizatidine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00041	0.00158	CcSEcCtD
Nizatidine—Headache—Fluorouracil—urinary bladder cancer	0.000408	0.00157	CcSEcCtD
Nizatidine—Asthenia—Etoposide—urinary bladder cancer	0.000406	0.00156	CcSEcCtD
Nizatidine—Back pain—Methotrexate—urinary bladder cancer	0.000402	0.00154	CcSEcCtD
Nizatidine—Pruritus—Etoposide—urinary bladder cancer	0.0004	0.00154	CcSEcCtD
Nizatidine—Nausea—Gemcitabine—urinary bladder cancer	0.000394	0.00151	CcSEcCtD
Nizatidine—Vomiting—Cisplatin—urinary bladder cancer	0.000393	0.00151	CcSEcCtD
Nizatidine—Rash—Cisplatin—urinary bladder cancer	0.000389	0.0015	CcSEcCtD
Nizatidine—Dermatitis—Cisplatin—urinary bladder cancer	0.000389	0.0015	CcSEcCtD
Nizatidine—Diarrhoea—Etoposide—urinary bladder cancer	0.000387	0.00149	CcSEcCtD
Nizatidine—Nausea—Fluorouracil—urinary bladder cancer	0.000387	0.00149	CcSEcCtD
Nizatidine—Anaemia—Methotrexate—urinary bladder cancer	0.000384	0.00148	CcSEcCtD
Nizatidine—Flatulence—Epirubicin—urinary bladder cancer	0.000383	0.00147	CcSEcCtD
Nizatidine—Tension—Epirubicin—urinary bladder cancer	0.000381	0.00147	CcSEcCtD
Nizatidine—Nervousness—Epirubicin—urinary bladder cancer	0.000377	0.00145	CcSEcCtD
Nizatidine—Back pain—Epirubicin—urinary bladder cancer	0.000376	0.00145	CcSEcCtD
Nizatidine—Dizziness—Etoposide—urinary bladder cancer	0.000374	0.00144	CcSEcCtD
Nizatidine—Nausea—Cisplatin—urinary bladder cancer	0.000367	0.00141	CcSEcCtD
Nizatidine—Cough—Methotrexate—urinary bladder cancer	0.000362	0.00139	CcSEcCtD
Nizatidine—Convulsion—Methotrexate—urinary bladder cancer	0.00036	0.00138	CcSEcCtD
Nizatidine—Vomiting—Etoposide—urinary bladder cancer	0.00036	0.00138	CcSEcCtD
Nizatidine—Anaemia—Epirubicin—urinary bladder cancer	0.000359	0.00138	CcSEcCtD
Nizatidine—Rash—Etoposide—urinary bladder cancer	0.000357	0.00137	CcSEcCtD
Nizatidine—Dermatitis—Etoposide—urinary bladder cancer	0.000356	0.00137	CcSEcCtD
Nizatidine—Headache—Etoposide—urinary bladder cancer	0.000354	0.00136	CcSEcCtD
Nizatidine—Flatulence—Doxorubicin—urinary bladder cancer	0.000354	0.00136	CcSEcCtD
Nizatidine—Myalgia—Methotrexate—urinary bladder cancer	0.000354	0.00136	CcSEcCtD
Nizatidine—Chest pain—Methotrexate—urinary bladder cancer	0.000354	0.00136	CcSEcCtD
Nizatidine—Tension—Doxorubicin—urinary bladder cancer	0.000353	0.00136	CcSEcCtD
Nizatidine—Nervousness—Doxorubicin—urinary bladder cancer	0.000349	0.00134	CcSEcCtD
Nizatidine—Back pain—Doxorubicin—urinary bladder cancer	0.000348	0.00134	CcSEcCtD
Nizatidine—Confusional state—Methotrexate—urinary bladder cancer	0.000342	0.00131	CcSEcCtD
Nizatidine—Cough—Epirubicin—urinary bladder cancer	0.000339	0.0013	CcSEcCtD
Nizatidine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000339	0.0013	CcSEcCtD
Nizatidine—Convulsion—Epirubicin—urinary bladder cancer	0.000337	0.00129	CcSEcCtD
Nizatidine—Infection—Methotrexate—urinary bladder cancer	0.000337	0.00129	CcSEcCtD
Nizatidine—Nausea—Etoposide—urinary bladder cancer	0.000336	0.00129	CcSEcCtD
Nizatidine—Anaemia—Doxorubicin—urinary bladder cancer	0.000332	0.00128	CcSEcCtD
Nizatidine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000332	0.00128	CcSEcCtD
Nizatidine—Myalgia—Epirubicin—urinary bladder cancer	0.000331	0.00127	CcSEcCtD
Nizatidine—Chest pain—Epirubicin—urinary bladder cancer	0.000331	0.00127	CcSEcCtD
Nizatidine—Anxiety—Epirubicin—urinary bladder cancer	0.00033	0.00127	CcSEcCtD
Nizatidine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000328	0.00126	CcSEcCtD
Nizatidine—Dry mouth—Epirubicin—urinary bladder cancer	0.000324	0.00124	CcSEcCtD
Nizatidine—Anorexia—Methotrexate—urinary bladder cancer	0.000323	0.00124	CcSEcCtD
Nizatidine—Confusional state—Epirubicin—urinary bladder cancer	0.00032	0.00123	CcSEcCtD
Nizatidine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000317	0.00122	CcSEcCtD
Nizatidine—Infection—Epirubicin—urinary bladder cancer	0.000315	0.00121	CcSEcCtD
Nizatidine—Cough—Doxorubicin—urinary bladder cancer	0.000314	0.00121	CcSEcCtD
Nizatidine—Convulsion—Doxorubicin—urinary bladder cancer	0.000312	0.0012	CcSEcCtD
Nizatidine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000311	0.00119	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000309	0.00119	CcSEcCtD
Nizatidine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000307	0.00118	CcSEcCtD
Nizatidine—Insomnia—Methotrexate—urinary bladder cancer	0.000307	0.00118	CcSEcCtD
Nizatidine—Myalgia—Doxorubicin—urinary bladder cancer	0.000306	0.00118	CcSEcCtD
Nizatidine—Chest pain—Doxorubicin—urinary bladder cancer	0.000306	0.00118	CcSEcCtD
Nizatidine—Anxiety—Doxorubicin—urinary bladder cancer	0.000305	0.00117	CcSEcCtD
Nizatidine—Anorexia—Epirubicin—urinary bladder cancer	0.000302	0.00116	CcSEcCtD
Nizatidine—Somnolence—Methotrexate—urinary bladder cancer	0.000301	0.00116	CcSEcCtD
Nizatidine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000299	0.00115	CcSEcCtD
Nizatidine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000298	0.00115	CcSEcCtD
Nizatidine—Confusional state—Doxorubicin—urinary bladder cancer	0.000296	0.00114	CcSEcCtD
Nizatidine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000295	0.00113	CcSEcCtD
Nizatidine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000293	0.00113	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000293	0.00113	CcSEcCtD
Nizatidine—Infection—Doxorubicin—urinary bladder cancer	0.000292	0.00112	CcSEcCtD
Nizatidine—Pain—Methotrexate—urinary bladder cancer	0.00029	0.00111	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000289	0.00111	CcSEcCtD
Nizatidine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000287	0.0011	CcSEcCtD
Nizatidine—Insomnia—Epirubicin—urinary bladder cancer	0.000287	0.0011	CcSEcCtD
Nizatidine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000284	0.00109	CcSEcCtD
Nizatidine—Somnolence—Epirubicin—urinary bladder cancer	0.000282	0.00108	CcSEcCtD
Nizatidine—Anorexia—Doxorubicin—urinary bladder cancer	0.00028	0.00108	CcSEcCtD
Nizatidine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000279	0.00107	CcSEcCtD
Nizatidine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000279	0.00107	CcSEcCtD
Nizatidine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000277	0.00107	CcSEcCtD
Nizatidine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000276	0.00106	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000274	0.00105	CcSEcCtD
Nizatidine—Constipation—Epirubicin—urinary bladder cancer	0.000271	0.00104	CcSEcCtD
Nizatidine—Pain—Epirubicin—urinary bladder cancer	0.000271	0.00104	CcSEcCtD
Nizatidine—Urticaria—Methotrexate—urinary bladder cancer	0.000269	0.00104	CcSEcCtD
Nizatidine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000268	0.00103	CcSEcCtD
Nizatidine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000268	0.00103	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000267	0.00103	CcSEcCtD
Nizatidine—Insomnia—Doxorubicin—urinary bladder cancer	0.000265	0.00102	CcSEcCtD
Nizatidine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000261	0.00101	CcSEcCtD
Nizatidine—Somnolence—Doxorubicin—urinary bladder cancer	0.000261	0.001	CcSEcCtD
Nizatidine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000259	0.000997	CcSEcCtD
Nizatidine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000258	0.000993	CcSEcCtD
Nizatidine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000255	0.000981	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000253	0.000974	CcSEcCtD
Nizatidine—Urticaria—Epirubicin—urinary bladder cancer	0.000252	0.000969	CcSEcCtD
Nizatidine—Pain—Doxorubicin—urinary bladder cancer	0.000251	0.000965	CcSEcCtD
Nizatidine—Constipation—Doxorubicin—urinary bladder cancer	0.000251	0.000965	CcSEcCtD
Nizatidine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000251	0.000964	CcSEcCtD
Nizatidine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000251	0.000964	CcSEcCtD
Nizatidine—Asthenia—Methotrexate—urinary bladder cancer	0.000243	0.000935	CcSEcCtD
Nizatidine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000242	0.00093	CcSEcCtD
Nizatidine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00024	0.000923	CcSEcCtD
Nizatidine—Pruritus—Methotrexate—urinary bladder cancer	0.00024	0.000922	CcSEcCtD
Nizatidine—Urticaria—Doxorubicin—urinary bladder cancer	0.000233	0.000897	CcSEcCtD
Nizatidine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000232	0.000892	CcSEcCtD
Nizatidine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000232	0.000892	CcSEcCtD
Nizatidine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000232	0.000892	CcSEcCtD
Nizatidine—Asthenia—Epirubicin—urinary bladder cancer	0.000228	0.000875	CcSEcCtD
Nizatidine—Pruritus—Epirubicin—urinary bladder cancer	0.000224	0.000863	CcSEcCtD
Nizatidine—Dizziness—Methotrexate—urinary bladder cancer	0.000224	0.000862	CcSEcCtD
Nizatidine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000217	0.000834	CcSEcCtD
Nizatidine—Vomiting—Methotrexate—urinary bladder cancer	0.000215	0.000829	CcSEcCtD
Nizatidine—Rash—Methotrexate—urinary bladder cancer	0.000214	0.000822	CcSEcCtD
Nizatidine—Dermatitis—Methotrexate—urinary bladder cancer	0.000213	0.000821	CcSEcCtD
Nizatidine—Headache—Methotrexate—urinary bladder cancer	0.000212	0.000816	CcSEcCtD
Nizatidine—Asthenia—Doxorubicin—urinary bladder cancer	0.000211	0.00081	CcSEcCtD
Nizatidine—Dizziness—Epirubicin—urinary bladder cancer	0.00021	0.000807	CcSEcCtD
Nizatidine—Pruritus—Doxorubicin—urinary bladder cancer	0.000208	0.000798	CcSEcCtD
Nizatidine—Vomiting—Epirubicin—urinary bladder cancer	0.000202	0.000775	CcSEcCtD
Nizatidine—Nausea—Methotrexate—urinary bladder cancer	0.000201	0.000774	CcSEcCtD
Nizatidine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000201	0.000772	CcSEcCtD
Nizatidine—Rash—Epirubicin—urinary bladder cancer	0.0002	0.000769	CcSEcCtD
Nizatidine—Dermatitis—Epirubicin—urinary bladder cancer	0.0002	0.000768	CcSEcCtD
Nizatidine—Headache—Epirubicin—urinary bladder cancer	0.000199	0.000764	CcSEcCtD
Nizatidine—Dizziness—Doxorubicin—urinary bladder cancer	0.000194	0.000746	CcSEcCtD
Nizatidine—Nausea—Epirubicin—urinary bladder cancer	0.000188	0.000724	CcSEcCtD
Nizatidine—Vomiting—Doxorubicin—urinary bladder cancer	0.000187	0.000718	CcSEcCtD
Nizatidine—Rash—Doxorubicin—urinary bladder cancer	0.000185	0.000712	CcSEcCtD
Nizatidine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000185	0.000711	CcSEcCtD
Nizatidine—Headache—Doxorubicin—urinary bladder cancer	0.000184	0.000707	CcSEcCtD
Nizatidine—Nausea—Doxorubicin—urinary bladder cancer	0.000174	0.00067	CcSEcCtD
